胶质母细胞瘤及神经球中CSPG4的组成性与TNFα诱导性表达:CAR-T细胞治疗的意义
胶质母细胞瘤(GBM)相关抗原表达异质性限制CAR-T疗效。研究发现硫酸软骨素蛋白聚糖4(CSPG4)在67%的GBM标本中高表达且异质性有限,并在GBM神经球(GBM-NS)中表达。CSPG4.CAR-T可有效控制GBM-NS体内外生长,对中低表达CSPG4的GBM-NS也有效,该效应由肿瘤周围小胶质细胞释放的TNFα诱导肿瘤细胞CSPG4上调介导。
要点
- CSPG4在67%的GBM标本中高表达且异质性有限。
- CSPG4.CAR-T可控制GBM-NS的体内外生长。
- TNFα诱导CSPG4上调可降低抗原逃逸风险。
核心结论
- CSPG4在GBM中的组成性和TNFα诱导性表达可能大大降低因靶抗原异质性表达而导致的肿瘤细胞逃逸风险。
研究设计与样本
- 研究检测了GBM标本中CSPG4的表达,并利用原代GBM来源的神经球(GBM-NS)进行体外和体内实验。
主要发现
- CSPG4在67%的GBM标本中高表达且异质性有限。
- CSPG4也在原代GBM来源的神经球(GBM-NS)中表达。
- CSPG4.CAR-T在体外和颅内接种后体内有效控制GBM-NS生长。
- CSPG4.CAR-T对中低表达CSPG4的GBM-NS也有效。
- 该效应由肿瘤周围小胶质细胞释放的TNFα诱导肿瘤细胞CSPG4体内上调介导。
临床怎么用
- CSPG4.CAR-T可能为GBM治疗提供新策略,尤其针对CSPG4高表达且异质性有限的GBM。
- TNFα诱导的CSPG4上调可能增强CAR-T对中低表达肿瘤的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The heterogeneous expression of tumor-associated antigens limits the efficacy of chimeric antigen receptor (CAR)-redirected T cells (CAR-Ts) for the treatment of glioblastoma (GBM). We have found that chondroitin sulfate proteoglycan 4 (CSPG4) is highly expressed in 67% of the GBM specimens with limited heterogeneity. CSPG4 is also expressed on primary GBM-derived cells, grown in vitro as neurospheres (GBM-NS), which recapitulate the histopathology and molecular characteristics of primary GBM. CSPG4.CAR-Ts efficiently controlled the growth of GBM-NS in vitro and in vivo upon intracranial tumor inoculation. Moreover, CSPG4.CAR-Ts were also effective against GBM-NS with moderate to low expression of CSPG4. This effect was mediated by the in vivo up-regulation of CSPG4 on tumor cells, induced by tumor necrosis factor-α (TNFα) released by the microglia surrounding the tumor. Overall, the constitutive and TNFα-inducible expression of CSPG4 in GBM may greatly reduce the risk of tumor cell escape observed when targeted antigens are heterogeneously expressed on tumor cells.
引用
- Pellegatta S, Savoldo B, Di Ianni N, et al. Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy. Sci Transl Med. 2018. PMID: 29491184. doi:10.1126/scitranslmed.aao2731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。